2024 Damon Runyon Clinical Investigator Award

2024 Damon Runyon Clinical Investigator Award

No applicants // Limit: 5 // Tickets Available: 5

 

The University of Arizona Cancer Center (UACC) can nominate five applications for the Damon Runyon Clinical Investigator Award
For more information please contact: UACC-PreAward.

 

The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.

The Clinical Investigator Award responds to three recognized realities:

  • Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
  • The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
  • The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.

The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.

The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

Funding Type
Internal Deadline
External Deadline
01/12/2024

Contact RDS

ResDev@arizona.edu 

(520) 621-8585 

1618 E. Helen St
Tucson, AZ 85719

Sign up for our newsletter